Researchers Database

suzuki hirotada

    CenterforPerinatalandNeonatalMedicine,DeliveryDivision Assistant Professor
Contact: killipjichi.ac.jp
Last Updated :2021/11/24

Researcher Information

URL

Research funding number

  • 90406116

J-Global ID

Research Interests

  • 医療・福祉   sEndoglin   妊娠高血圧腎症   sFlt-1   HO-1   産科学   アデノウィルス   soluble endoglin   PlGF   

Research Areas

  • Life sciences / Obstetrics and gynecology

Academic & Professional Experience

  • 2014  Jichi Medical UniversitySchool of Medicine助教

Published Papers

  • Shigeki Matsubara, Tomoyuki Kuwata, Yosuke Baba, Rie Usui, Hirotada Suzuki, Hironori Takahashi, Akihide Ohkuchi, Mitsuaki Suzuki
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY 54 (3) 283 - 286 0004-8666 2014/06 [Refereed][Not invited]
     
    Although massive haemorrhage at caesarean section (CS) for placenta praevia is a serious concern, effective treatment is not yet determined. We performed a new uterine sandwich to achieve haemostasis at CS for total placenta praevia in five consecutive cases in whom the placenta reached up to >5cm from the internal cervical os in all directions of an uterine wall. A Matsubara-Yano (MY) uterine compression suture was placed, followed by placement of an intrauterine balloon. Haemostasis was achieved in all five cases with median blood loss of 1618mL. No short-term adverse events were observed. The MY sandwich can be used to achieve haemostasis at CS for placenta praevia.
  • Chikako Hirashima, Akihide Ohkuchi, Kayo Takahashi, Hirotada Suzuki, Shigeki Matsubara, Mitsuaki Suzuki
    HYPERTENSION RESEARCH 37 (6) 519 - 525 0916-9636 2014/06 [Refereed][Not invited]
     
    Our aim was to develop a novel screening method to detect the imminent onset of preeclampsia (PE) within 4 weeks after blood sampling. We prospectively collected data regarding past history of PE/gestational hypertension (GH), blood pressure levels at 16-23 weeks and plasma levels of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) twice at 19-31 weeks, which were measured using an automated electrochemiluminescence immunoassay. We found that a three-step approach by sequential selection using maternal factors, including a past history of PE/GH or blood pressure levels >= 120/80mmHg at 16-23 weeks (first step), followed by plasma levels of PlGF in the < 5th percentile (second step) and plasma levels of sFlt-1 in the >= 95th percentile (third step) yielded both high sensitivity and specificity. The imminent onset of PE occurred in 2 of 1199 (0.2%) women recruited at 19-25 weeks and in 6 of 798 (0.8%) women recruited at 26-31 weeks. The sensitivity, specificity, positive likelihood ratio (95% confidence interval), negative likelihood ratio (95% confidence interval), positive predictive value and negative predictive value of the three-step approach for predicting the imminent onset of PE at 19-25 weeks were 100%, 99.8%, 599 (150-2390), 0%, 50% and 100%, respectively; and those at 26-31 weeks were 83%, 99.1%, 94 (42-214), 0.17 (0.03-1.01), 42% and 99.9%, respectively. In conclusion, the three-step approach is a highly sensitive and specific screening method for detecting the imminent onset of PE within 4 weeks after blood sampling at 19-31 weeks of gestation.
  • Yosuke Baba, Shigeki Matsubara, Akihide Ohkuchi, Rie Usui, Tomoyuki Kuwata, Hirotada Suzuki, Hironori Takahashi, Mitsuaki Suzuki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH 40 (5) 1243 - 1248 1341-8076 2014/05 [Refereed][Not invited]
     
    AimIn placenta previa (PP), anterior placentation, compared with posterior placentation, is reported to more frequently cause massive hemorrhage during cesarean section (CS). Whether this is due to the high incidence of placenta accreta, previous CS, or a transplacental approach in anterior placenta is unclear. We attempted to clarify this issue. Material and MethodsWe retrospectively analyzed the relation between the bleeding amount during CS for PP and various factors that may cause massive hemorrhage (>2400mL) (n=205) in a tertiary center. If the preoperatively ultrasound-measured distance from the internal cervical ostium to the placental edge was longer in the uterine anterior wall than in the posterior wall, we defined it as anterior previa, and vice versa. ResultsPatients with accreta, previous CS, total previa, and anterior placentation bled significantly more than their counterparts. Multivariate logistic regression analysis showed that accreta (odds ratio [OR] 12.6), previous CS (OR 4.7), total previa (OR 4.1), and anterior placentation (OR 3.5) were independent risk factors of massive hemorrhage. ConclusionsAnterior placentation, namely, the placenta with a longer os-placental edge distance in the anterior wall than in the posterior wall, was a risk of massive hemorrhage during CS for PP.
  • Kenji Horie, Hirotada Suzuki, Akihide Ohkuchi, Shigeki Matsubara, Tomokazu Ikemoto, Mitsuaki Suzuki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH 40 (2) 590 - 594 1341-8076 2014/02 [Refereed][Not invited]
     
    Recently, transient inferior vena cava (IVC) filters have been employed to protect against pulmonary embolism (PE) in pregnant women with deep vein thrombosis. A 34-year-old primiparous Japanese woman with a history of myomectomy was diagnosed with deep vein thrombosis by ultrasound at 27 weeks of gestation. Unfractionated heparin was administered, which soon ameliorated swelling in the right thigh. A transient IVC filter was implanted just before cesarean section. An enhanced computed tomography scan 2 days after cesarean section revealed a wide thrombus just distal to the filter. We performed catheter thrombus fragmentation with fibrinolysis just before the removal of the IVC filter, resulting in re-canalization of blood flow. No significant PE occurred. Although a transient IVC filter may work well for the prophylaxis of PE during labor and delivery, catheter fragmentation with fibrinolysis may become necessary at removal of the filter.
  • Chikako Hirashima, Akihide Ohkuchi, Kayo Takahashi, Hirotada Suzuki, Yoshio Matsuda, Shigeki Matsubara, Mitsuaki Suzuki
    HYPERTENSION RESEARCH 37 (1) 76 - 81 0916-9636 2014/01 [Refereed][Not invited]
     
    It has not been clarified whether high mean blood pressure (HBP) of >= 90 mm Hg and bilateral notching (BN) on uterine artery Doppler additively affect the subsequent circulating levels of placental growth factor (PlGF), soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sEng). Serum levels of PlGF, sFlt-1 and sEng at 17-25 weeks and 26-32 weeks were measured in all women with HBP+BN- (n=272), HBP-BN+ (n=130) and HBP+BN+ (n=60) in 1239 eligible women, and 338 consecutive women with HBP-BN- were selected from the remaining 777 women. Only data before the onset of preeclampsia were evaluated. The cutoff value of an abnormal decrease of PlGF was set at the 5th percentile, and those of an abnormal increase of sFlt-1, sFlt-1/PlGF and sEng were set at the 95th percentile. The frequency of HBP in those with BN- was almost the same as that in those with BN+ (25.9% vs. 26.7%). In women with HBP-BN-, HBP-BN+, HBP+BN- and HBP+BN+, the frequency of abnormal sFlt-1/PlGF ratio at 26-32 weeks was 6.6%, 9.2%, 14.4% and 22.8%, respectively; and the frequency of abnormal sFlt-1/PlGF ratio at 26-32 weeks in those with HBP+BN+ was significantly increased than in HBP-BN-. Similarly, in the four groups, the frequency of abnormal sEng at 26-32 weeks was 5.4%, 2.5%, 12.2% and 19.0%, respectively; and the frequency in those with HBP+BN+ was significantly increased than in HBP-BN-. In conclusion, high BP levels and abnormal uterine artery Doppler may be additively implicated in circulating abnormalities of angiogenesis-related factors.
  • Akihide Ohkuchi, Chikako Hirashima, Kayo Takahashi, Hirotada Suzuki, Shigeki Matsubara, Mitsuaki Suzuki
    Hypertension Research 36 (12) 1073 - 1080 0916-9636 2013/12 [Refereed][Not invited]
     
    Our aim was to evaluate the onset threshold of plasma levels of the soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio for predicting the imminent onset of preeclampsia (PE) within 4 weeks after blood sampling. We prospectively measured the plasma levels of sFlt-1 and PlGF by an automated electrochemiluminescence immunoassay at 19-25 weeks of gestation in 1199 women and at 26-31 weeks of gestation in 798 women. The onset threshold of the sFlt-1/PlGF ratio was determined as the 2.5th percentile of the 95th confidence interval (CI) of a regression line between the onset gestational weeks of PE and the standard deviation score of log 10 (sFlt-1/PlGF), using 25 samples taken within 1 week after the onset of PE. The imminent onset of PE was identified in 2 (0.2%) women recruited at 19-25 weeks and in 6 (0.8%) women recruited at 26-31 weeks. The onset threshold of plasma levels of the sFlt-1/PlGF ratio at 19-25 weeks showed a sensitivity (SE) of 1.00, a specificity (SP) of 1.00, a positive likelihood ratio (LR+) of ∞ and a positive predictive value (PPV) of 1.00 the onset threshold of plasma levels of the sFlt-1/PlGF ratio at 26-31 weeks showed a SE of 0.83, a SP of 0.994, a LR+ of 132 (95% CI: 51-339) and a PPV of 0.50. In conclusion, the onset threshold of plasma levels of the sFlt-1/PlGF ratio was shown to be a highly sensitive and a highly specific screening method for detecting the imminent onset of PE within 4 weeks after blood sampling at 19-31 weeks. © 2013 The Japanese Society of Hypertension All rights reserved.
  • Shigeki Matsubara, Yosuke Baba, Hirotada Suzuki, Haruna Suzuki, Tomomi Nagashima, Mitsuaki Suzuki
    Acta Obstetricia et Gynecologica Scandinavica 92 (10) 1234 - 1235 0001-6349 2013/10 [Refereed][Not invited]
  • Suzuki H, Kuwata T, Ohkuchi A, Yada Y, Matsubara S, Suzuki M
    Case reports in obstetrics and gynecology 2013 345808  2090-6684 2013 [Refereed][Not invited]
  • Chikako Hirashima, Akihide Ohkuchi, Kayo Takahashi, Hirotada Suzuki, Mika Yoshida, Takako Ohmaru, Kazuo Eguchi, Haruko Ariga, Shigeki Matsubara, Mitsuaki Suzuki
    HYPERTENSION RESEARCH 34 (2) 212 - 217 0916-9636 2011/02 [Refereed][Not invited]
     
    It is controversial whether gestational hypertension (GH) and preeclampsia (PE) have the same pathophysiology. Our aim was to clarify whether the serum soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio and levels of soluble endoglin (sEng) are different in women with GH and with PE. In women with GH (15 cases), hypertension preceding PE (h-PE, 10 cases) and PE in which hypertension and proteinuria occurred simultaneously (si-PE, 36 cases), blood samples were collected after disease onset. The levels of log(10)(sFlt-1/PlGF) in women with GH were significantly lower than in women with h-PE and si-PE (1.65 +/- 0.39 vs. 2.22 +/- 0.35 and 2.15 +/- 0.46). The levels of log(10)sEng in women with GH were also significantly lower than in women with h-PE and si-PE (1.51 +/- 0.43 vs. 1.87 +/- 0.21 and 1.85 +/- 0.32). The incidence rates of the sFlt-1/PlGF ratio >= 95th percentile of the reference value were 73, 100 and 92%, respectively, (P=0.080), and those of sEng >= 95th percentile were 67, 100 and 89%, respectively, (P=0.053). In conclusion, the levels of sFlt-1/PlGF ratio and sEng in women with GH were lower than in those with h-PE and with si-PE; however, the majority of women with GH showed abnormal increases of both sFlt-1/PlGF ratio and sEng, suggesting that GH may be a subclinical PE in view of serum levels of angiogenesis-related factors. Hypertension Research (2011) 34, 212-217; doi: 10.1038/hr.2010.212; published online 4 November 2010
  • Akihide Ohkuchi, Chikako Hirashima, Hirotada Suzuki, Kayo Takahashi, Mika Yoshida, Shigeki Matsubara, Mitsuaki Suzuki
    HYPERTENSION RESEARCH 33 (5) 422 - 427 0916-9636 2010/05 [Refereed][Not invited]
     
    The first commercial automated immunoassays specific for soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) (Elecsys sFlt-1 and Elecsys PlGF, respectively) have recently been introduced. We constructed reference range values of plasma levels of sFlt-1 and PlGF, and the sFlt-1/PlGF ratio using Elecsys sFlt-1 and Elecsys PlGF during the second half of pregnancy and evaluated their sensitivity and specificity for the diagnosis of preeclampsia. Plasma samples were collected from 144 normal pregnant women at 19-25, 27-31 and 34-38 weeks of gestation and from 34 women with preeclampsia. The most appropriate reference range curves for plasma levels of sFlt-1 and PlGF, and the sFlt-1/PlGF ratio are presented as quadratic curves after logarithmic transformation. The sFlt-1/PlGF ratio showed the best diagnostic power for both early-onset and late-onset preeclampsia. In addition, a cutoff value of 45 for the sFlt-1/PlGF ratio resulted in the best sensitivity and specificity for the diagnosis of all preeclampsia (97 and 95%, respectively), and for the diagnosis of early-onset preeclampsia (100 and 95%, respectively). Using another 50 pairs of serum and plasma samples, including those from normal pregnant women and preeclamptic women, the plasma recovery rates of sFlt-1 and PlGF were 0.89 and 0.85, respectively; the correlation determinations between serum and plasma samples were 0.999 for sFlt-1, 0.990 for PlGF and 0.987 for sFlt-1/PlGF ratio. In conclusion, measurement of the plasma sFlt-1/PlGF ratio determined by Elecsys sFlt-1 and Elecsys PlGF and using a cutoff value of 45 might assist in the diagnosis of preeclampsia, especially for early-onset preeclampsia. Hypertension Research (2010) 33, 422-427; doi: 10.1038/hr.2010.15; published online 12 February 2010

MISC



Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.